Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle

被引:29
作者
Cicoira, Mariantonietta [1 ]
Anker, Stefan D. [2 ]
Ronco, Claudio [3 ]
机构
[1] Univ Verona, Dept Med, Cardiol Sect, I-37100 Verona, Italy
[2] Campus Virchow Klinikum, Dept Cardiol, Charite Med Sch, Berlin, Germany
[3] San Bortolo Hosp, Dept Nephrol Dialysis & Transplantat, Int Renal Res Inst IRRIV, Vicenza, Italy
关键词
Cardio-renal syndromes; Heart; Kidney; CHRONIC HEART-FAILURE; TUMOR-NECROSIS-FACTOR; CHRONIC KIDNEY-DISEASE; INDEPENDENT RISK-FACTOR; ACUTE-RENAL-FAILURE; FACTOR-ALPHA; ATHEROSCLEROSIS RISK; INSULIN-RESISTANCE; PLASMA GHRELIN; MUSCLE MASS;
D O I
10.1007/s13539-011-0038-2
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
030301 [社会学]; 100201 [内科学];
摘要
Cardio-renal syndromes (CRS) are defined as disorders of the heart and kidney whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction of the other. CRS have been classified into five categories, where types 2 and 4 represent respectively chronic cardio-renal and chronic reno-cardiac syndromes. In these conditions, the chronic disorder of either the heart or kidney has been shown to induce some degree of cachexia. At the same time, cachexia has been proposed as a possible mechanism contributing to the worsening of such pathological organ cross talk. Common pathogenetic mechanisms underlie body wasting in cachectic states of different chronic heart and kidney diseases. In these circumstances, a vicious circle could arise, in which cachexia associated with either heart failure or chronic kidney disease may contribute to further damage of the other organ. In chronic CRS, activation of the immune and neuroendocrine systems contributes to the genesis of cachexia, which in turn can negatively affect the heart and kidney function. In patients with cardiac sustained activation of the immune and neuroendocrine systems and oxidative stress, renal vascular resistance can increase and therefore impair renal perfusion, leading to worsening kidney function. Similarly, in renal cachexia, increased levels of pro-inflammatory cytokines can cause progressive left ventricular systolic dysfunction, myocardial cell death, endothelial dysfunction and increased myocardial fibrosis, with consequent impairment of the chronic reno-cardiac syndrome type 4. Thus, we speculate that the occurrence of different types of chronic CRS could represent a fundamental step in the genesis of cachexia, being renal and cardiac dysfunction closely related to the occurrence of systemic disorders leading to a final common pathway. Therefore, the heart and kidney and cachexia represent a triad causing a vicious circle that increases mortality and morbidity: In such circumstances, we may plausibly talk about cardio-renal cachexia syndrome. Complex interrelations may explain the transition from CRS to cachexia and from cachexia to CRS. Identification of the exact mechanisms occurring in these conditions could potentially help in preventing and treating this deadly combination.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 102 条
[1]
EDEMA OF CARDIAC ORIGIN - STUDIES OF BODY-WATER AND SODIUM, RENAL-FUNCTION, HEMODYNAMIC INDEXES, AND PLASMA HORMONES IN UNTREATED CONGESTIVE CARDIAC-FAILURE [J].
ANAND, IS ;
FERRARI, R ;
KALRA, GS ;
WAHI, PL ;
POOLEWILSON, PA ;
HARRIS, PC .
CIRCULATION, 1989, 80 (02) :299-305
[2]
Anker SD, 1997, EUR HEART J, V18, P259
[3]
Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure [J].
Anker, SD ;
Ponikowski, PP ;
Clark, AL ;
Leyva, F ;
Rauchhaus, M ;
Kemp, M ;
Teixeira, MM ;
Hellewell, PG ;
Hooper, J ;
Poole-Wilson, PA ;
Coats, AJS .
EUROPEAN HEART JOURNAL, 1999, 20 (09) :683-693
[4]
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study [J].
Anker, SD ;
Negassa, A ;
Coats, AJS ;
Afzal, R ;
Poole-Wilson, PA ;
Cohn, JN ;
Yusuf, S .
LANCET, 2003, 361 (9363) :1077-1083
[5]
Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure [J].
Anker, SD ;
Volterrani, M ;
Egerer, KR ;
Felton, CV ;
Kox, WJ ;
Poole-Wilson, PA ;
Coats, AJS .
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1998, 91 (03) :199-203
[6]
Wasting as independent risk factor for mortality in chronic heart failure [J].
Anker, SD ;
Ponikowski, P ;
Varney, S ;
Chua, TP ;
Clark, AL ;
WebbPeploe, KM ;
Harrington, D ;
Kox, WJ ;
PooleWilson, PA ;
Coats, AJS .
LANCET, 1997, 349 (9058) :1050-1053
[7]
Anker SD, 1997, CIRCULATION, V96, P526
[8]
Hypercatabolism and hypermetabolism in wasting states [J].
Baracos, VE .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2002, 5 (03) :237-239
[9]
Kidney-heart interactions: Epidemiology, pathogenesis, and treatment [J].
Berl, Tomas ;
Henrich, William .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (01) :8-18
[10]
Renal insufficiency as an independent predictor of mortality among women with heart failure [J].
Bibbins-Domingo, K ;
Lin, F ;
Vittinghof, E ;
Barrett-Connor, E ;
Grady, D ;
Shlipak, MG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (08) :1593-1600